← Back to Search

Advanced Driver Assistance System

Lane change assistance system for Parkinson's Disease

N/A
Waitlist Available
Led By Liliana Alvarez, PhD
Research Sponsored by Western University, Canada
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants must be 21 years of age or older (as a feasibility study, this study will provide the opportunity to participate to those diagnosed with early onset PD)
Have been diagnosed with Parkinson's disease by a neurologist or movement disorder specialist
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 4 weeks, and 6 weeks
Awards & highlights

Study Summary

This trial will test whether a lane-change assistance system can help people with Parkinson's disease drive more safely.

Eligible Conditions
  • Parkinson's Disease
  • Drunk Driving

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 4 weeks, and 6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 4 weeks, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in number of lane maintenance errors from baseline to post-test 1(4 weeks) and post-test 2 (6 weeks)
Change in number of signalling errors from baseline to post-test 1(4 weeks) and post-test 2 (6 weeks)
Change in number of visual scanning errors from baseline to post-test 1(4 weeks) and post-test 2 (6 weeks)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Participants will complete a standardized battery of paper and pencil and computer tests. Following these tests, participants will complete a baseline simulator driving assessment without any form of assistive technology. We will employ a CDS-200 driving simulator (DriveSafety Inc., Salt Lake City, UT). A trained blinded evaluator will observe the recorded drive and score the drive. After the baseline assessment, participants will engage in 3 intervention sessions (lasting 30 minutes each). During these sessions, the lane change assistance system will be introduced and participants will be taught how to use it. After the 3 sessions, participants will participate in a post-test, similar to the baseline assessment but with a different route within the simulated world. They will drive this new route with the assistive technology. One to two weeks after the post-test, participants will be invited to participate in a follow-up assessment (battery of tests and simulator assessment).
Group II: ControlActive Control1 Intervention
Participants will complete a standardized battery of paper and pencil and computer tests. Following these tests, participants will complete a baseline simulator driving assessment without any form of assistive technology. We will employ a CDS-200 driving simulator (DriveSafety Inc., Salt Lake City, UT). A trained blinded evaluator will observe the recorded drive and score the drive. After the baseline assessment, participants will engage in 3 intervention sessions (lasting 30 minutes each). During these sessions, participants will drive the scenario and receive feedback from a trained evaluator regarding their live performance. No lane change assistance system will be utilized. After the 3 sessions, participants will participate in a post-test, similar to the baseline assessment but with a different route within the simulated world.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Lane change assistance system
2019
N/A
~30

Find a Location

Who is running the clinical trial?

Western University, CanadaLead Sponsor
238 Previous Clinical Trials
57,160 Total Patients Enrolled
Liliana Alvarez, PhDPrincipal InvestigatorWestern University, Canada
1 Previous Clinical Trials
8 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research endeavor have any open slots for participants?

"Affirmative, the data present on clinicaltrials.gov shows that this experimental trial is currently searching for suitable volunteers. The experiment was originally posted in April of 2019 and recently updated in 2021 with a target group size of 24 individuals at a single medical facility."

Answered by AI

How many subjects are currently enrolled in this clinical experiment?

"Absolutely. Per the information posted on clinicaltrials.gov, this medical experiment is still searching for participants to join. It was initially publicized on April 15th 2019 and later updated on April 5th 2021. The study requires 24 individuals at a single research centre to take part in the trial."

Answered by AI
~4 spots leftby Mar 2025